Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-10 Wilkins H Jeffrey Chief Medical Officer Purchase +912 $2.28 $2K 27,002
2021-05-18 ARMISTICE CAPITAL, LLC Director Purchase +22,000 $2.33 $51K 39,100,000
2021-05-18 ARMISTICE CAPITAL, LLC Director Purchase +0 39,100,000
2021-05-17 ARMISTICE CAPITAL, LLC Director Purchase +30,000 $2.20 $66K 39,078,000
2021-05-17 ARMISTICE CAPITAL, LLC Director Purchase +0 39,078,000
2021-05-14 ARMISTICE CAPITAL, LLC Director Purchase +128,000 $2.15 $275K 39,048,000
2021-05-14 ARMISTICE CAPITAL, LLC Director Purchase +0 39,048,000
2021-04-15 ARMISTICE CAPITAL, LLC Director Conversion +6,285,715 $2.00 $12.6M 38,920,000
2021-04-15 ARMISTICE CAPITAL, LLC Director Conversion +0 38,920,000
2021-04-15 ARMISTICE CAPITAL, LLC Director Conversion · SERIES B NON-VOTING CONVERTIBLE PREFERRED STOCK −1,257,143 0
2021-04-15 ARMISTICE CAPITAL, LLC Director Conversion · SERIES B NON-VOTING CONVERTIBLE PREFERRED STOCK −0 0
2021-04-01 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +70,881 70,881
2021-03-31 Gutry Phil Director Grant or award · Stock Option (Right to Buy) +3,783 3,783
2021-03-31 Miller Joseph M Director Grant or award · Stock Option (Right to Buy) +5,564 5,564
2021-03-31 Persson Magnus Director Grant or award · Stock Option (Right to Buy) +4,799 4,799
2021-03-31 Bruhn Suzanne Louise Director Grant or award · Stock Option (Right to Buy) +4,173 4,173
2021-03-31 KAPLAN GILLA Director Grant or award · Stock Option (Right to Buy) +7,650 7,650
2021-03-01 Greenway Schond L. CFO & Treasurer Grant or award · Stock Option (Right to Buy) +500,000 500,000
2021-01-26 Sullivan Christopher Ryan Interim CFO Grant or award · Stock Option (Right to Buy) +110,000 110,000
2021-01-26 COLA MICHAEL F Chief Executive Officer Grant or award · Stock Option (Right to Buy) +850,000 850,000

Page 18 of 25 · 500 trades